In a new study, researchers at Karolinska Institutet have identified the presence of a specific connection between a protein and an lncRNA molecule in liver cancer. By increasing the presence of the lncRNA molecule, the fat depots of the tumor cell decrease, which causes the division of tumor cells to cease, and they eventually die. The study, published in the journal Gut, contributes to increased knowledge that can add to a better diagnosis and future cancer treatments.
Bioelectricity, the current that flows between our cells, is fundamental to our ability to think and talk and walk.
In addition, there is a growing body of evidence that recording and altering the bioelectric fields of cells and tissue plays a vital role in wound healing and even potentially fighting diseases like cancer and heart disease.
Now, for the first time, researchers at the USC Viterbi School of Engineering have created a molecular device that can do both: Record and manipulate its surrounding bioelectric field.
DeepScribe, an AI-powered medical transcription platform, has raised $30 million in Series A funding led by Nina Achadjian at Index Ventures, with participation from Scale.ai CEO Alex Wang, Figma CEO Dylan Field and existing investors Bee Partners, Stage 2 Capital and 1984 Ventures. The company’s latest round of funding follows its $5.2 million seed round announced in May 2021. DeepScribe was founded in 2017 by Akilesh Bapu, Matthew Ko and Kairui Zeng with the aim of unburdening doctors from tedious data entry and allowing them to focus on their patients.
In 2019, DeepScribe launched its ambient voice AI technology that summarizes natural patient-physician conversations. The idea for DeepScribe was prompted by Bapu and Ko’s own experiences. Bapu’s father was an oncologist and he saw the toll that documentation had on his father’s work/life balance. On the other hand, Ko saw how the burden of clinical documentation was impacting patients’ perception of care when he was the care coordinator for his mother when she was diagnosed with breast cancer.
After being frustrated with the care his mother was receiving, Ko turned to Bapu and his father for help. The pair then began to understand the importance of clinical documentation and realized that recent breakthroughs in artificial intelligence and natural language processing were not being used to remedy the situation. They then decided to create a platform that would address the problem.
University of Utah engineers have built a robotic exoskeleton that gives people with prosthetic legs a power boost that makes walking less difficult.
“It’s equivalent to taking off a 26-pound backpack [while walking],” lead researcher Tommaso Lenzi said in a press release. “That is a really big improvement.”
The challenge: About 220,000 people in the U.S. have had above-knee amputations, meaning their leg was amputated somewhere between the knee and hip.
Excerpt from an interview made by James Ruhle, founder at Simple Biotech, to Michael (Mike) West, founder and CEO of AgeX Therapeutics.
During this 4 minute excerpt, Mike explains in a nutshell the work he and his team at AgeX are doing “to reverse the aging of cells and tissues in the body in the truest and fullest sense of the work”, and clarifies the reasons why it doesn’t mean to convert and adult into a child.
To watch the entire interview clic here: https://youtu.be/nv3DYGw5iVM
